CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BusinessWire Biotech
Original article

Union Pacific Reports Second Quarter 2026 Results

EarningsPositive
AI Analysis

Summary

Union Pacific Corporation reported Q2 2026 net income of $2.0 billion (up 6%) and diluted EPS of $3.36 (up 7%) compared to Q2 2025. This is a non-biotech transportation/railroad company earnings report not relevant to pharmaceutical or biotech sector analysis.

Financial Highlights

EPS

$3.36

Importance:1/10
Sentiment:
0.40
earningsQ2_2026not_biotech
Related Companies

Read the original article

Published by BusinessWire Biotech on July 23, 2026 11:45 AM

Read Original